alexa Toxic Leucoencephalopathy Due to CHOP Therapy in a Patient with NonHodgkin’s Lymphoma | Open Access Journals
ISSN: 2165-7920
Journal of Clinical Case Reports
Make the best use of Scientific Research and information from our 700+ peer reviewed, Open Access Journals that operates with the help of 50,000+ Editorial Board Members and esteemed reviewers and 1000+ Scientific associations in Medical, Clinical, Pharmaceutical, Engineering, Technology and Management Fields.
Meet Inspiring Speakers and Experts at our 3000+ Global Conferenceseries Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on
Medical, Pharma, Engineering, Science, Technology and Business

Toxic Leucoencephalopathy Due to CHOP Therapy in a Patient with NonHodgkin’s Lymphoma

Chetanya Malik*, Aditya Kutiyal, Sanjay Pandit, Sandeep Garg and Naresh Gupta

Maulana Azad Medical College, New Delhi, India

*Corresponding Author:
Chetanya Malik
Maulana Azad Medical College
New Delhi, India
Tel: 011 2323 9279
E-mail: [email protected]

Received Date: May 28, 2017 Accepted Date: August 18, 2017 Published Date: August 24, 2017

Citation: Malik C, Kutiyal A, Pandit S, Garg S, Gupta N (2017) Toxic Leucoencephalopathy Due to CHOP Therapy in a Patient with NonHodgkin’s Lymphoma. J Clin Case Rep 7: 1006. doi: 10.4172/2165- 7920.10001006

Copyright: © 2017 Malik C, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Visit for more related articles at Journal of Clinical Case Reports

Abstract

Toxic leucoencephalopathy is damage to cerebral white matter due to exposure to cranial irradiation, environmental toxins, drugs of abuse and chemotherapeutic agents. It results in wide variety of clinical manifestations like personality change, inattention, memory loss, abulia, stupor, coma and death. It leads to white matter demyelination which is visible on T2 weighted MRI as hyperintensity. We report a rare case of a 14-year-old boy with large B cell lymphoma who developed toxic leucoencephalopathy due to exposure to CHOP regimen.

Keywords

Toxic; Leucoencephalopathy; Non-hodgkin’s lymphoma; CHOP

Introduction

Leucoencephalopathy is structural alteration in cerebral white matter due to myelin damage. Toxic leucoencephalopathy is caused by cranial irradiation, environmental toxins, drugs of abuse and chemotherapeutic agents. It causes symptoms ranging from forgetfulness, inattention and personality change to dementia, coma and death. We present here a case of toxic leucoencephalopathy in a patient with non-hodgkin’s lymphoma.

Case Report

A 14-year-old boy presented with complaints of moderate grade fever associated with loss of appetite and easy fatigability for last 20- 25 days and black tarry liquid stools for last 7-10 days. There was no history of jaundice, abdominal distension, pedal edema or weight loss. On examination the patient was conscious, oriented and vitals were stable. There was pallor and peticheal rash present diffusely on bilateral lower limbs and abdomen. There was single right submandibular lymph node of size 1.5 cm by 2 cm. On per abdomen examination, liver was palpable 6 cm below the costal margin and spleen was palpable 8 cm below the costal margin. Laboratory investigations revealed severe pancytopenia with Hemoglobin (Hb) of 3.8 g/dl, Total leucocyte count (TLC) of 290 cells/mm3 with 18% polymorphs, 82% lymphocytes and 2% monocytes and platelet count(P/C) of 8,000/mm3. ESR was 104 mm. Kidney function tests (KFT), liver function tests (LFT), serum calcium, phosphate, serum protein and albumin were within normal limits. Peripheral smear showed no atypical cells. CECT chest and abdomen revealed hepatosplenomegaly with multiple lymph nodes in right paratracheal, pre- and para- tracheal, pre-and sub-carinal region largest measuring 11 mm. Lymph node biopsy of the submandibular lymph node was suggestive of reactive lymphadenitis. Bone marrow aspirate was suggestive of few atypical cells, while biopsy revealed large atypical cells having vesicular nuclei and moderate to abundant vacuolated cytoplasm. Many cells showed prominent nucleoli and nuclear grooving and many mitotic figures were also seen. Immunophenotyping showed atypical cells are strongly positive for CD 19 and CD 10, weakly positive for LCA and negative for CD45RO, CD34, CD68, CD30, ALK and antiMPO. On the basis of above findings, a diagnosis of stage IV Large B cell Non-Hodgkin’s lymphoma was made and was started on CHOP regimen that included Injection (inj.) Cyclophosphamide 750 mg/ m2, Inj. Doxorubicin 50 mg/m2, Inj. Vincristine 1.4 mg/m2 and tablet prednisolone 40 mg/m2 for 5 days.

Around 10 days after completing the second cycle of chemotherapy, patient was admitted with the complaints of inability to pay attention, decreased sleep, agitated behavior and abusive speech for last 2 days. There was no history of fever, headache or vomiting. There was no history of visual abnormality, weakness of any limb or history suggestive of cranial nerve abnormality. There was no history of sensory loss, gait abnormality or seizures. On examination, meningeal signs and neck rigidity were absent. Patient was conscious, oriented but agitated and unco-operative. His higher mental function could not be assessed because of agitated and unco-operative behavior. Rest of the central nervous system examination was normal.

Investigations revealed normal Hemoglobin, total leucocyte count, platelet count, KFT, LFT and serum calcium and phosphate. Cerebrospinal fluid (CSF) analysis revealed no cells, glucose of 66 mg/ dl and protein of 20 mg/dl. CSF culture showed no growth. CSF sent for TBPCR, HSV PCR, Cryptococcal antigen were negative. CSF sent for malignant cells did not show any atypical cells on analysis. NCCT head revealed periventricular hypodensities in bilateral frontal region. MRI brain as shown in Figures 1 and 2 revealed confluent, symmetric hyperintensity in periventricular white matter in B/L frontal regions on T2 and FLAIR images with no restricted diffusion and contrast enhancement. There were few areas of subcortical white matter hyperintensity. There was no meningeal enhancement, lymphomatous deposits, hydrocephalus or any granuloma.

clinical-case-reports-periventricular

Figure 1: T2 MRI BRAIN image showing periventricular hyperintensity in white matter.

clinical-case-reports-hyperintensity

Figure 2: FLAIR MRI image showing similar area with hyperintensity.

On the basis of neurobehavioural manifestations in a patient of Non-Hodgkin’s lymphoma who has received chemotherapy in the form of CHOP therapy and corroborative imaging findings with lack of any feature suggestive of CNS involvement in lymphoma or any infectious cause, a diagnosis of toxic leucoencephalopathy due to CHOP therapy was made.

Patient was initially managed with parenteral antipsychotics and benzodiazepines, after which the patient improved in 1 week. His 3rd cycle of chemotherapy was delayed by approximately 10 days due to the above manifestations. These neurobehavioural manifestations did not recur again and patient had completed 6 cycles of chemotherapy. Repeat bone marrow examination revealed no atypical cells and repeat CT scan showed normal size of liver and spleen without any intraabdominal or mediastinal lymphadenopathy. His MRI brain repeated after the 6th cycle showed similar symmetric, confluent periventricular hyper intensity as seen in previous MR imaging.

Discussion and Conclusion

Toxic leucoencephalopathy should be considered a possibility in a patient with neurobehavioural manifestations and exposure to toxins causing white matter damage. The range of disease severity varies from mild cases resulting in inattention and forgetfulness to severe disease resulting in dementia, coma and death [1]. It does not usually affect language function [2]. The diagnosis of this rare but increasingly recognised clinical entity requires exposure to toxin, neurobehavioural manifestations and neuroradiological abnormalities consistent with the diagnosis.

Among various neuroimaging modalities, T2 weighted MRI is the imaging of choice because of its ability to display white matter changes [3]. T2, DWI and FLAIR shows symmetrical and confluent white matter hyperintensity initially involving periventricular white matter in mild cases to diffuse involvement with areas of necrosis in cerebral white matter.

While toxic leucoencephalopathy is well known with various chemotherapeutic changes especially methotrexate, CHOP therapy related leucoencephalopathy is very rarely reported in literature. Cain et al. reported first such case report in 1998 which was a severe form of disease and was fatal [4]. The therapy needs to be stopped in severe cases, however in our case we had a patient with mild disease and therapy was completed. Thus, all neurobehavioural manifestations must be thoroughly evaluated and investigations in a patient with exposure to toxins keeping in mind the possibility of toxic leucoencephalopathy.

References

Select your language of interest to view the total content in your interested language
Post your comment

Share This Article

Relevant Topics

Article Usage

  • Total views: 232
  • [From(publication date):
    August-2017 - Oct 22, 2017]
  • Breakdown by view type
  • HTML page views : 200
  • PDF downloads :32
 

Post your comment

captcha   Reload  Can't read the image? click here to refresh

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri, Food, Aqua and Veterinary Science Journals

Dr. Krish

[email protected]

1-702-714-7001 Extn: 9040

Clinical and Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemical Engineering and Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001 Extn: 9040

Earth & Environmental Sciences

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

General Science and Health care Journals

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics and Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001 Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Informatics Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Material Sciences Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Mathematics and Physics Journals

Jim Willison

[email protected]

1-702-714-7001 Extn: 9042

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001 Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

John Behannon

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001 Extn: 9042

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords